Diuretics Pharmacology Flashcards

1
Q

Mannitol MOA

A

Osmotic diuretic. Increase tubular fluid osmolarity–> increases urine flow, decreases intracranial/intraocular pressure. Acts primarily in proximal tubule.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mannitol clinical use

A

Drug overdose, elevated intracranial/intraocular pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mannitol toxicity

A

Pulmonary edema, dehydration, contraindicated in anuria, HF.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Acetazolamide MOA

A

Carbonic anyhydrase inhibitor. Causes self limited NaHCO3 diuresis and decreased total bicarb stores. Acts in proximal tubule. Reduces bicarb and Na+ reabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Acetazolamide clinical use

A

Glaucoma, urinary alkalinization, metabolic alkalosis, altitude sickness, psuedotumor cerebri.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Acetazolamide toxicity

A

Hyperchloremic metabolic acidosis, paresthesias, NH3 toxicity, sulfa allergy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Loop diuretics (3 names)

A

Furosemide, bumetanide, torsemide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Loop diuretic MOA

A

Sulfonamide loop diuretics. Inhibit cotransport system (Na+/K+/2Cl-) of thick ascending limb of loop of henle. Prevent concentration of urine by abolishing hypertonicity of medulla. Increases Na+, K+, H20 excretion. Stimulate PGE release (vasodilatory effect on afferent arteriole). Increase Ca++ excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Loop diuretic clinical uses

A

Edema (HF, cirrosis, nephrotic syndrome, pulmonary edema). HTN, hypercalcemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Loop diuretic toxicity

A

Ototoxicity, Hypokalemia, Dehydration, Allergy, Nephritis, Gout (OH DANG)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ethacrynic acid MOA

A

Phenoxyacetic acid derivative. Same action as furosemide (but not sulfonamide)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ethacrynic acid clinical use

A

Diuresis in patients with a sulfa allergy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ethacrynic acid toxicity

A

Similar to furosemide. Can cause hyperuricemia. Never use to treat gout.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Thiazide diuretics (3 names)

A

Chlorthalidone, hydrochlorothiazide, metaloxone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Thiazide MOA

A

Inhibit NaCl reabsorption in the early DCT. Decrease diluting capacity of nephron. Decrease Ca++ excretion. Opens K+ channels–> hyperpolarize vessels–>vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Thiazide clinical use

A

HTN, HF, idiopathic hypercalciuria, nephrogenic diabetes insipidus, osteoporosis.

17
Q

Thiazide toxicity

A

Hypokalemic metabolic acidosis, hyponatremia, hyperglycemia, hyperlipidemia, hyperuricemia, hypercalcemia, sufla allergy.

18
Q

How do thiazides cause hyperglycemia?

A

Bind to SUR on K+ channel controlling insulin release–> opens channel–> hyperpolarizes beta cell–> suppresses insulin release–> hyperglycemia

19
Q

K+ sparing diuretics (4 drugs)

A

Spironolactone and eplernone, triamterene, amiloride

20
Q

Spironolactone and eplernone MOA

A

Competitive aldosterone receptor antagonists in cortical collecting tubule.

21
Q

Triamterene and amiloride MOA

A

Block ENaC–> block the Na+ exchange for K+ and H+ in cortical collecting tubule.

22
Q

K+ sparing diuretic clinical use

A

Mild diuretics, hyperaldosteronism, K+ depletion, HF. Spironolactone used post-MI for cardiac remodeling

23
Q

K+ sparing toxicity

A

Hyperkalemia (can cause arrhythmias), hypercholeremic metabolic acidosis, endocrine effects with spironolactone (gynecomastia, antiandrogen effects). Triamterene + indomethacin can cause ARF, kidney stones

24
Q

ADH and congeners (Vasopressin and desmopressin) MOA

A

Stimulate GPCR–>Gs–>cAMP–>PKA–> increase aquaporins–> allows for concentration of urine. Act in the medullary collecting duct

25
SGLT inhibitors (3 drugs)
Canigliflozin, dapagliflozin, gliflozin
26
SGLT inhibitor MOA
Inhibit SGLT2-->reduce glucose reabsorption--> loss of glucose in urine. Acts in proximal tubule.
27
ADH uses
Diabetes insipidus, bedwetting
28
SGLT inhibitor clinical uses
Reduce blood sugar levels in DM (adjunctive), causes weight loss (loss of energy in form of glucose)
29
SGLT inhibitor toxicity
Ketoacidosis, UTI, yeast infections, hypoglycemia
30
Organic Anion Transport (OAT) inhibitors (2)
Probenicid, sulfinpyrazone
31
OAT inhibitor MOA
Act in proximal tubule. Driven by symport/antiport exchange of molecules for dicarboxylates, facilitate excretion, suppress uric acid reabsorption, critical molecule = urate
32
OAT inhibitor uses
Gout treatment
33
Allopurinol MOA
Inhibits xanthine oxidase formation
34
Colchicine MOA
Microtubule inhibitor w/anti-inflammatory properties